Infective Endocarditis in Low- and Middle-Income Countries

被引:29
作者
Njuguna, Benson [1 ,3 ]
Gardner, Adrian [2 ,5 ]
Karwa, Rakhi [3 ,5 ]
Delahaye, Francois [4 ]
机构
[1] Moi Teaching & Referral Hosp, Dept Pharm, POB 3, Eldoret 30100, Kenya
[2] Indiana Univ Sch Med, Dept Med, 340 West 10th St 6200, Indianapolis, IN 46202 USA
[3] Purdue Univ, Coll Pharm, Dept Pharm Practice, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA
[4] Univ Claude Bernard, Equipe Accueil HESPER 7425, Hosp Civils Lyon, Hop Louis Pradel,Dept Cardiol, 28 Ave Doyen Lepine, F-69677 Lyon, France
[5] POB 3, Eldoret 30100, Kenya
关键词
Endocarditis in LMIC; Developing countries; Causes; Management; Challenges; TERTIARY CARE CENTER; NATIVE VALVE ENDOCARDITIS; RHEUMATIC HEART-DISEASE; STAPHYLOCOCCUS-AUREUS; 5-YEAR EXPERIENCE; GLOBAL BURDEN; EARLY SURGERY; SOUTH-AFRICA; RISK-FACTORS; MORTALITY;
D O I
10.1016/j.ccl.2016.08.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infective endocarditis (IE) is a rare, life-threatening disease with a mortality rate of 25% and significant debilitating morbidities. Although much has been reported on contemporary IE in high-income countries, conclusions on the state of IE in low and middle-income countries (LMICs) are based on studies conducted before the year 2000. Furthermore, unique challenges in the diagnosis and management of IE persist in LMICs. This article reviews IE studies conducted in LMICs documenting clinical experiences from the year 2000 to 2016. Presented are the causes of IE, management of patients with IE, and prevailing challenges in diagnosis and treatment of IE in LMICs.
引用
收藏
页码:153 / +
页数:12
相关论文
共 61 条
[1]   Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis [J].
Alsan, Marcella ;
Schoemaker, Lena ;
Eggleston, Karen ;
Kammili, Nagamani ;
Kolli, Prasanthi ;
Bhattacharya, Jay .
LANCET INFECTIOUS DISEASES, 2015, 15 (10) :1203-1210
[2]   Clinical microbiology in developing countries [J].
Archibald, LK ;
Reller, LE .
EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :302-305
[3]   Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association [J].
Baddour, Larry M. ;
Wilson, Walter R. ;
Bayer, Arnold S. ;
Fowler, Vance G., Jr. ;
Tleyjeh, Imad M. ;
Rybak, Michael J. ;
Barsic, Bruno ;
Lockhart, Peter B. ;
Gewitz, Michael H. ;
Levison, Matthew E. ;
Bolger, Ann F. ;
Steckelberg, James M. ;
Baltimore, Robert S. ;
Fink, Anne M. ;
O'Gara, Patrick ;
Taubert, Kathryn A. .
CIRCULATION, 2015, 132 (15) :1435-1486
[4]   The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? [J].
Bannay, Aurelie ;
Hoen, Bruno ;
Duval, Xavier ;
Obadia, Jean-Francois ;
Selton-Suty, Christine ;
Le Moing, Vincent ;
Tattevin, Pierre ;
Iung, Bernard ;
Delahaye, Francois ;
Alla, Francois .
EUROPEAN HEART JOURNAL, 2011, 32 (16) :2003-2015
[5]  
BENNIS A, 1995, ANN CARDIOL ANGEIOL, V44, P339
[6]   Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam [J].
Burgess, Lindsey D. ;
Drew, Richard H. .
PHARMACOTHERAPY, 2014, 34 (07) :670-676
[7]  
Cabell Christopher H., 2003, Cardiology Clinics, V21, P147, DOI 10.1016/S0733-8651(03)00033-X
[8]   Infective endocarditis [J].
Cahill, Thomas J. ;
Prendergast, Bernard D. .
LANCET, 2016, 387 (10021) :882-893
[9]   The global burden of group A streptococcal diseases [J].
Carapetis, JR ;
Steer, AC ;
Mulholland, EK ;
Weber, M .
LANCET INFECTIOUS DISEASES, 2005, 5 (11) :685-694
[10]   Cardiovascular Disease in the Developing World [J].
Celermajer, David S. ;
Chow, Clara K. ;
Marijon, Eloi ;
Anstey, Nicholas M. ;
Woo, Kam S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (14) :1207-1216